Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Pharmacokinetics and Pharmacodynamics of Anastrozole in Pubertal Boys with Recent Onset Gynecomastia
Journal of Clinical Endocrinology and Metabolism, 06/11/09
Mauras N et al. - Anastrozole is a potent aromatase inhibitor in adolescent males, with rapid absorption and slow elimination kinetics after oral dosing. Exploratory analysis of changes in breast size showed breast reduction in the cohort; this deserves further study.
Related Articles
Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III tandem study
Journal of Clinical Oncology, 10/01/09
Relevance Score: 96%
Randomized Biomarker Trial of Anastrozole or Low-Dose Tamoxifen or Their Combination in Subjects with Breast Intraepithelial Neoplasia
Clinical Cancer Research, 11/06/09
Relevance Score: 89%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Autoimmune Thyroid Disease in Pregnancy: A Review
Journal of Women's Health, 12/10/09
Effect of Raloxifene on Serum Lipids for Type 2 Diabetic Menopausal Women with or without Statin Treatment
Medical Principles and Practice, 12/10/09
Influence of BMI, Age and Duration of Diabetes Mellitus on Glycaemic Control with Twice-Daily Injections of Biphasic Insulin Aspart 30 versus Multiple Daily Injections of Insulin Aspart (JDDM 18): Retrospective Reanalysis of a 6-Month, Randomized, Open-Label, Multicentre Trial in Japan
Clinical Drug Investigation, 12/10/09
Today in Reproductive Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effect of Metformin Treatment for 2 Years without Caloric Restriction on Endocrine and Metabolic Parameters in Women with Polycystic Ovary Syndrome
Experimental and Clinical Endocrinology & Diabetes, 12/10/09
Estrogen receptor [beta] ligands: Recent advances and biomedical applications
Medicinal Research Reviews, 12/10/09
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome
Diabetes Care, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


